C. Roe

C. Xiong, D. Carr, C. Roe, 2015, The American journal of occupational therapy : official publication of the American Occupational Therapy Association.

Longitudinal Driving Performance in Early‐Stage Dementia of the Alzheimer Type

J. Duchek, J. Morris, C. Xiong, 2003, Journal of the American Geriatrics Society.

Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease

Charles D. Smith, J. Morris, R. Petersen, 2009, Neurobiology of Aging.

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

D. Y. Lee, W. M. van der Flier, Linda J. C. van Waalwijk van Doorn, 2015, JAMA.

Association of Cerebral Amyloid-&bgr; Aggregation With Cognitive Functioning in Persons Without Dementia

D. Y. Lee, W. M. van der Flier, Linda J. C. van Waalwijk van Doorn, 2018, JAMA psychiatry.

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.

A. Fagan, D. Head, M. Mintun, 2009, Archives of neurology.

Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions

Brian A. Gordon, J. Morris, Yi Su, 2018, Neurology.

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

A. Fagan, M. Mintun, J. Morris, 2007, Archives of neurology.

Preclinical Alzheimer's disease and longitudinal driving decline

Chengjie Xiong, Brian R. Ott, Peggy P. Barco, 2016, Alzheimer's & dementia.

Brain amyloid in preclinical Alzheimer's disease is associated with increased driving risk

Brian R. Ott, Peter J. Snyder, David B. Carr, 2016, Alzheimer's & Dementia.

Alzheimer disease family history impacts resting state functional connectivity

Chengjie Xiong, Abraham Z Snyder, J. Morris, 2012, Annals of neurology.

EFFECT OF THE L-ARGININE-NITRIC OXIDE PATHWAY ON HUMAN PLACENTAL VASCULAR

C. Roe, Roger Smith, I. Leitch, 1997 .

Nitric oxide regulation of corticotropin-releasing hormone release from the human perfused placenta in vitro.

R. Smith, C. Roe, I. Leitch, 1996, The Journal of clinical endocrinology and metabolism.

Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need

L. Schneider, H. Snyder, A. Brickman, 2018, Alzheimer's & Dementia.

The interaction of sleep and amyloid deposition on cognitive performance

C. Roe, Yo-El S. Ju, Y. S. Ju, 2017, Journal of sleep research.

Physical Activity and Cognitive Trajectories in Cognitively Normal Adults: The Adult Children Study

D. Head, J. Morris, E. Grant, 2014, Alzheimer disease and associated disorders.

The ideological divide in confidence in science and participation in medical research

J. Morris, M. Gabel, C. Roe, 2021, Scientific reports.

Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type.

A. Fagan, A. Shah, J. Morris, 2009, Archives of neurology.

Evaluation of Naturalistic Driving Behavior Using In-Vehicle Monitoring Technology in Preclinical and Early Alzheimer’s Disease

Jennifer D. Davis, Christopher B. Rosnick, G. Papandonatos, 2020, Frontiers in Psychology.

Depression is Associated with Tau and Not Amyloid Positron Emission Tomography in Cognitively Normal Adults.

J. Morris, B. Ances, C. Roe, 2020, Journal of Alzheimer's disease : JAD.

Resting State Functional Connectivity Signature Differentiates Cognitively Normal from Individuals Who Convert to Symptomatic Alzheimer Disease

A. Fagan, B. Ances, C. Roe, 2020 .

Older Adults’ Expectations about Mortality, Driving Life and Years Left without Driving

B. Zikmund‐Fisher, D. Carr, C. Roe, 2019, Journal of gerontological social work.

A Naturalistic Study of Driving Behavior in Older Adults and Preclinical Alzheimer Disease: A Pilot Study

J. Morris, T. Benzinger, D. Carr, 2019, Journal of applied gerontology : the official journal of the Southern Gerontological Society.

Progression of Alzheimer’s disease as measured by Clinical Dementia Rating Sum of Boxes scores

John C. Morris, J. Morris, M. Storandt, 2013, Alzheimer's & Dementia.

Use of Anticholinergic Medications by Older Adults with Dementia

C. Roe, B. Spivack, Michael J. Anderson, 2002, Journal of the American Geriatrics Society.

Concomitant Use of Antipsychotics and Drugs That May Prolong the QT Interval

C. Roe, R. Henderson, K. Odell, 2003, Journal of clinical psychopharmacology.

A 2.5-Year Longitudinal Assessment of Naturalistic Driving in Preclinical Alzheimer's Disease.

Jennifer D. Davis, D. Head, B. Ances, 2019, Journal of Alzheimer's disease : JAD.

Creating a driving profile for older adults using GPS devices and naturalistic driving methodology.

J. Morris, D. Carr, C. Roe, 2016, F1000Research.

Naturalistic driving measures of route selection associate with resting state networks in older adults

Nicholas V. Metcalf, J. Morris, B. Ances, 2021, Scientific reports.

Alzheimer's disease identification using amyloid imaging and reserve variables: Proof of concept

D. Marcus, M. Mintun, J. Morris, 2010, Alzheimer's & Dementia.

J. Morris, N. Cairns, A. Goate, 2016, Alzheimer's & Dementia.

Improving Our Understanding of Driving Changes in Preclinical and Early Symptomatic Alzheimer’s Disease: The Role of Naturalistic Driving Studies

C. Roe, 2022, Journal of Alzheimer's disease reports.

BRAIN AMYLOID IN PRECLINICAL ALZHEIMER’S DISEASE IS ASSOCIATED WITH INCREASED DRIVING RISK

P. Snyder, D. Carr, Richard N. Jones, 2016, Alzheimer's & Dementia.

Driving, Social Distancing, Protective, and Coping Behaviors of Older Adults Before and During COVID-19

C. Roe, G. Babulal, Ann M. Johnson, 2022, Journal of applied gerontology : the official journal of the Southern Gerontological Society.

Political Ideology, Confidence in Science, and Participation in Alzheimer Disease Research Studies

J. Morris, M. Gabel, C. Roe, 2018, Alzheimer disease and associated disorders.

IMPACT OF COGNITIVE RESERVE AND PRECLINICAL AD ON LONGITUDINAL DRIVING PERFORMANCE

A. Fagan, J. Morris, D. Holtzman, 2017, Alzheimer's & Dementia.

Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels.

A. Fagan, D. Head, J. Morris, 2016, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Effect of the L-Arginine-Nitric Oxide Pathway on Human Placental Vascular Tone and Corticotropin-Releasing Hormone Secretion

W. Walters, C. Roe, Roger Smith, 1997 .

The complex relationship between depression and progression to incident cognitive impairment across race and ethnicity

C. Roe, G. Babulal, Monique M. Williams, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Driving assessment in preclinical Alzheimer’s disease: progress to date and the path forward

C. Roe, Sayeh Bayat, 2022, Alzheimer's Research & Therapy.

Genetic differences between symptomatic and asymptomatic persons with Alzheimer's disease neuropathologic change

J. Morris, N. Cairns, A. Goate, 2015, Alzheimer's & Dementia.

Characteristics of Previously Forgotten Memories of Sexual Abuse: A Descriptive Study

C. Roe, M. Schwartz, 1996 .

Validity and reliability of the AD8 informant interview in dementia

J. Morris, C. Xiong, C. Roe, 2006, Neurology.

Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology

J. Morris, N. Cairns, W. Kukull, 2013, Neurology.

Increased susceptibility to oxidative death of lymphocytes from Alzheimer patients correlates with dementia severity.

C. Xiong, C. Roe, M. Behrens, 2014, Current Alzheimer research.

Apolipoprotein Eε4 modifies Alzheimer's disease onset in an E280A PS1 kindred

Kenneth S. Kosik, Francisco Lopera, Pau Pastor, 2003 .

Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease

Ge Li, Jeffrey A. Kaye, R. Reid Townsend, 2011, PloS one.

YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease

Chengjie Xiong, John X. Morris, Ge Li, 2010, Biological Psychiatry.

The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia

Brian A. Gordon, John C. Morris, J. Morris, 2015, NeuroImage: Clinical.

Moonlighting activity of presenilin in plants is independent of γ-secretase and evolutionarily conserved

R. Quatrano, C. Roe, Raphael Kopan, 2007, Proceedings of the National Academy of Sciences.

Cerebrospinal fluid biomarkers, education, brain volume, and future cognition.

A. Fagan, D. Marcus, M. Mintun, 2011, Archives of neurology.

Gender- and Age-Related Prescription Drug Use Patterns

C. Roe, B. Motheral, Catherine M Roe, 2002, The Annals of pharmacotherapy.

Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.

Karen M Rodrigue, Frederik Barkhof, Timo Grimmer, 2015, JAMA.

Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults.

Yvette I Sheline, J. Morris, Y. Sheline, 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology

Sally R. Ellingson, J. Morris, N. Cairns, 2017, Alzheimer disease and associated disorders.

Association of Functional Impairments and Co-Morbid Conditions with Driving Performance among Cognitively Normal Older Adults

J. Morris, C. Xiong, D. Carr, 2016, PloS one.

Identification of Genes that Modify the Age of Onset in a Large Familial Alzheimer's Disease Kindred

A. Goate, K. Kosik, J. Norton, 2005 .

Apolipoprotein E ε 4 Modifies Alzheimer ’ s Disease Onset in an E 280 A PS 1 Kindred

G. Bedoya, A. Goate, K. Kosik, 2003 .

Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake.

M. Mintun, J. Morris, C. Xiong, 2008, Archives of neurology.

Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease

A. Fagan, A. Shah, D. Marcus, 2009, EMBO molecular medicine.

Preclinical Alzheimer disease and risk of falls

A. Fagan, J. Morris, V. Buckles, 2013, Neurology.

Clinicopathologic study of Alzheimer's disease: Alzheimer mimics.

J. Morris, V. Buckles, Y. Shim, 2013, Journal of Alzheimer's disease : JAD.

Evaluation of cognitive impairment in older adults: combining brief informant and performance measures.

J. Morris, C. Roe, J. Galvin, 2007, Archives of neurology.

Inverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer's patients and skin cancer survivors: increased apoptosis in Alzheimer's and reduced necrosis in cancer.

C. Xiong, C. Roe, M. Behrens, 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

Keith A. Johnson, D. Y. Lee, W. M. van der Flier, 2022, JAMA neurology.

Longitudinal Changes in Anger, Anxiety, and Fatigue Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease.

C. Roe, Ling Chen, G. Babulal, 2022, Journal of Alzheimer's disease : JAD.

J. Morris, A. Goate, N. Cairns, 2016, JAMA neurology.

Neuropsychological changes in asymptomatic persons with Alzheimer disease neuropathology

Walter Kukull, Jason Hassenstab, J. Morris, 2014, Neurology.

Education and Alzheimer disease without dementia

J. Morris, J. Miller, C. Xiong, 2007, Neurology.

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

A. Fagan, M. Mintun, J. Morris, 2013, Alzheimer's & Dementia.

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease

D. Y. Lee, A. Fagan, J. Morris, 2017, Alzheimer's & Dementia.

GPS driving: a digital biomarker for preclinical Alzheimer disease

A. Fagan, J. Morris, C. Roe, 2021, Alzheimer's research & therapy.

Resting State Functional Connectivity Signature Differentiates Cognitively Normal from Individuals Who Convert to Symptomatic Alzheimer's Disease.

A. Fagan, J. Morris, B. Ances, 2020, Journal of Alzheimer's disease : JAD.

CSF biomarkers of Alzheimer disease

A. Fagan, J. Morris, D. Holtzman, 2013, Neurology.

Role of family history for Alzheimer biomarker abnormalities in the adult children study.

D. Balota, J. Duchek, A. Fagan, 2011, Archives of neurology.

Everyday Driving and Plasma Biomarkers in Alzheimer's Disease: Leveraging Artificial Intelligence to Expand Our Diagnostic Toolkit.

J. Morris, B. Ances, C. Roe, 2023, Journal of Alzheimer's disease : JAD.

Limited Longitudinal Change in Self-reported Spatial Navigation Ability in Preclinical Alzheimer Disease

A. Fagan, D. Head, C. Roe, 2021, Alzheimer disease and associated disorders.

Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers

A. Fagan, D. Head, J. Morris, 2018, Brain : a journal of neurology.

Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers

A. Fagan, D. Head, J. Morris, 2018, Alzheimer's & Dementia.

Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.

J. Morris, B. Ances, D. Carr, 2017, Journal of Alzheimer's disease : JAD.

Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report.

A. Fagan, D. Head, J. Morris, 2017, Journal of Alzheimer's disease : JAD.

Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.

A. Fagan, J. Morris, D. Holtzman, 2016, Journal of Alzheimer's Disease.

Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results.

J. Morris, M. Gabel, C. Roe, 2015, JAMA neurology.

Neuropsychological Markers of Cognitive Decline in Persons With Alzheimer Disease Neuropathology

J. Morris, N. Cairns, W. Kukull, 2015, Journal of neuropathology and experimental neurology.

Alzheimer disease

D. Rentz, C. Roe, 2013, Neurology.

Lack of association between acute stroke, post-stroke dementia, race, and β-amyloid status

J. Morris, J. Shimony, C. Xiong, 2021, NeuroImage: Clinical.

Recruitment of African American and Non-Hispanic White Older Adults for Alzheimer Disease Research Via Traditional and Social Media: a Case Study

C. Roe, G. Babulal, Sarah H Stout, 2020, Journal of Cross-Cultural Gerontology.

Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults: Role of Spatial Navigation Abilities

A. Fagan, D. Head, J. Morris, 2018, Alzheimer disease and associated disorders.

Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals

A. Fagan, D. Head, J. Morris, 2017, Alzheimer disease and associated disorders.

Clinical features of Alzheimer disease with and without lewy bodies

J. Morris, N. Cairns, C. Roe, 2015, Alzheimer's & Dementia.

“Noncognitive” symptoms of early Alzheimer disease

J. Morris, C. Roe, John C Morris, 2015, Neurology.

Relationship Between Late-Life Hypertension, Blood Pressure, and Alzheimer’s Disease

J. Morris, C. Roe, Yuan-Han Yang, 2011, American journal of Alzheimer's disease and other dementias.

Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease

John X. Morris, A. Fagan, D. Marcus, 2011, Neurology.

Alzheimer disease identification using amyloid imaging and reserve variables

D. Marcus, M. Mintun, J. Morris, 2010, Neurology.

Autobiographical memory task in assessing dementia.

J. Morris, C. Roe, D. Dreyfus, 2010, Archives of neurology.

Is there a link between dementia and cancer

C. Roe, M. Behrens, A. Quest, 2010 .

Thyroid Medication Use and Subsequent Development of Dementia of the Alzheimer Type

P. C. Harper, C. Roe, 2010, Journal of geriatric psychiatry and neurology.

"...frequently-cited characteristics associated with tumor development are increases in cell proliferation and a reduction in the susceptibility to apoptosis - the opposite of what occurs in neurodegenerative diseases."

C. Roe, M. Behrens, A. Quest, 2010 .

Inverse Association between Cancer and Dementia of the Alzheimer’s Type

J. Morris, C. Roe, M. Pellegrino, 2008 .

Education and reported onset of symptoms among individuals with Alzheimer disease.

J. Morris, J. Miller, C. Xiong, 2008, Archives of neurology.

Patient's rating of cognitive ability: using the AD8, a brief informant interview, as a self-rating tool to detect dementia.

J. Morris, M. Coats, C. Roe, 2007, Archives of neurology.

Inverse Association between Cancer and Dementia of the Alzheimer ’ s Type 119

C. Roe, M. Behrens, J. Morris, 2007 .

The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs

J. Morris, D. McKeel, C. Roe, 2005, Neurology.

Impaired Physical Performance and the Assessment of Dementia of the Alzheimer Type

J. Morris, J. Miller, D. Carr, 2004, Alzheimer disease and associated disorders.

Compliance with and dosing of angiotensin-converting-enzyme inhibitors before and after hospitalization.

M. Rich, C. Roe, B. Motheral, 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure.

M. Rich, C. Roe, B. Motheral, 1999, American heart journal.

Identifying Preclinical Alzheimer's Disease Using Everyday Driving Behavior: Proof of Concept.

A. Fagan, J. Morris, C. Roe, 2020, Journal of Alzheimer's disease : JAD.

Development and interval testing of a naturalistic driving methodology to evaluate driving behavior in clinical research.

C. Roe, G. Babulal, Sarah H Stout, 2016, F1000Research.

Exploration of 100 commonly used drugs and supplements on cognition in older adults

J. Morris, C. Roe, Karen R. Obermann, 2013, Alzheimer's & Dementia.

Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer disease

J. Morris, A. Goate, N. Cairns, 2017, Neurology.

Cognitive impairments and mood disruptions negatively impact instrumental activities of daily living performance in the first three months after a first stroke

L. Connor, C. Roe, G. Babulal, 2015, Topics in stroke rehabilitation.

Cancer linked to Alzheimer disease but not vascular dementia

J. Miller, L. Kuller, C. Xiong, 2010, Neurology.

Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred.

G. Bedoya, A. Goate, K. Kosik, 2003, Annals of neurology.

Unified Parkinson's Disease Rating Scale-Motor Exam: inter-rater reliability of advanced practice nurse and neurologist assessments.

Chengjie Xiong, John C. Morris, J. Morris, 2010, Journal of advanced nursing.

Amyloid imaging and cerebrospinal fluid biomarkers predict driving performance in preclinical Alzheimer's disease

A. Fagan, D. Head, J. Morris, 2015, Alzheimer's & Dementia.

Naturalistic driving measures of route selection associate with resting state networks in older adults

John X. Morris, Nicholas V. Metcalf, B. Ances, 2022, Scientific Reports.

How Many Patients Complete an Adequate Trial of Donepezil?

C. Roe, B. Spivack, Michael J. Anderson, 2002, Alzheimer disease and associated disorders.

Interaction of Neuritic Plaques and Education Predicts Dementia

J. Morris, J. Miller, C. Xiong, 2008, Alzheimer disease and associated disorders.

Mild Physical Impairment Predicts Future Diagnosis of Dementia of the Alzheimer's Type

J. Morris, Consuelo H. Wilkins, C. Roe, 2013, Journal of the American Geriatrics Society.

The Effect of APOE &egr;4 Allele on Cholinesterase Inhibitors in Patients With Alzheimer Disease: Evaluation of the Feasibility of Resting State Functional Connectivity Magnetic Resonance Imaging

J. Morris, B. Ances, C. Roe, 2014, Alzheimer disease and associated disorders.

Stability of the Clinical Dementia Rating, 1979-2007.

J. Morris, C. Roe, Monique M. Williams, 2009, Archives of neurology.

The relationship between mood states and preclinical Alzheimer disease in older adults

D. Head, J. Morris, D. Carr, 2015, Alzheimer's & Dementia.

Driving Outcomes among Older Adults: A Systematic Review on Racial and Ethnic Differences over 20 Years

C. Roe, G. Babulal, Sarah H Stout, 2018, Geriatrics.

Adverse driving behaviors are associated with sleep apnea severity and age in cognitively normal older adults at risk for Alzheimer's disease.

A. Fagan, J. Morris, D. Holtzman, 2022, Sleep.

COVID‐19 and preclinical Alzheimer disease: Driving, mobility, activity and experiences of older adults in the United States

J. Morris, C. Roe, G. Babulal, 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Identifying preclinical Alzheimer disease from driving patterns: A machine learning approach

A. Fagan, J. Morris, C. Roe, 2021, Alzheimer's & Dementia.

Reaction to a Pandemic: Social Distancing and Driving Among Older Adults During COVID-19

Christopher B. Rosnick, C. Roe, G. Babulal, 2020, Journal of applied gerontology : the official journal of the Southern Gerontological Society.

A brief clinical tool to assess physical function: the mini-physical performance test.

J. Morris, Consuelo H. Wilkins, C. Roe, 2010, Archives of gerontology and geriatrics.

The Importance of Advancing Research on Aging and Driving

C. Roe, G. Babulal, S. Murphy, 2021, Geriatrics.

Pathological Correlates of White Matter Hyperintensities on Magnetic Resonance Imaging

J. Morris, C. Xiong, N. Cairns, 2014, Dementia and Geriatric Cognitive Disorders.

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease

D. Y. Lee, A. Fagan, A. Fleisher, 2017, Alzheimer's & Dementia.

Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease

Charles D. Smith, R. Petersen, V. Buckles, 2009, Neurobiology of Aging.

PATIENT CHARACTERISTICS AND OUTCOMES ASSOCIATED WITH RECEIVING AN EARLIER VERSUS LATER DIAGNOSIS OF PROBABLE ALZHEIMER’S DISEASE: EVIDENCE FROM THE NATIONAL ALZHEIMER’S COORDINATING CENTER DATA

A. Goate, N. Cairns, Carlos Cruchaga, 2016, Alzheimer's & Dementia.

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

A. Fagan, M. Mintun, D. Holtzman, 2013, Alzheimer's & Dementia.

AD and cancer

C. Roe, M. Behrens, 2013, Neurology.

Relationship Between Late-Life Hypertension, Blood Pressure, and Alzheimer’s Disease

C. Roe, Yuan-Han Yang, J. Morris, 2011, American journal of Alzheimer's disease and other dementias.

Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need

L. Schneider, H. Snyder, A. Brickman, 2018, Alzheimer's & Dementia.

Physical Activity and Cognitive Trajectories in Cognitively Normal Adults: The Adult Children Study

D. Head, E. Grant, C. Roe, 2014, Alzheimer disease and associated disorders.

Stability of the Clinical Dementia Rating, 1979-2007.

C. Roe, Monique M. Williams, J. Morris, 2009, Archives of neurology.

Pathological Correlates of White Matter Hyperintensities on Magnetic Resonance Imaging

C. Xiong, N. Cairns, Y. Shim, 2014, Dementia and Geriatric Cognitive Disorders.

Mood changes in cognitively normal older adults are linked to Alzheimer’s disease biomarker levels

D. Head, D. Holtzman, C. Roe, 2016 .

Associations Between Plasma, Imaging, and Cerebrospinal Fluid Biomarkers with Driving Behavior and Cognitive Tests: Implications for Biomarker Usefulness

C. Roe, G. Babulal, Sayeh Bayat, 2023, Journal of Alzheimer's disease reports.

Association of Cerebral Amyloid-&bgr; Aggregation With Cognitive Functioning in Persons Without Dementia

D. Y. Lee, W. M. van der Flier, Linda J. C. van Waalwijk van Doorn, 2018, JAMA psychiatry.

Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.

B. Ances, D. Carr, Brian L. Ott, 2017, Journal of Alzheimer's disease : JAD.